This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Rooting out recurrent breast cancer

February 8th, 2013

Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat.

In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy. In a mouse model of breast cancer, TGF-β both diverted cells down a path to becoming cancerous and allowed for cancer to come back after treatment.

Importantly, loss of TGF-β prevented tumor recurrence in mice. These studies identify a mechanism by which cancer cells elude standard chemotherapy and provide a rationale for testing the therapeutic potential of agents that block TGF-β.

More information:
TGFβ inhibition enhances chemotherapy action against triple negative breast cancer, Journal of Clinical Investigation

Provided by Journal of Clinical Investigation

Citation: Rooting out recurrent breast cancer (2013, February 8) retrieved 2 August 2026 from https://sciencex.com/wire-news/121786792/rooting-out-recurrent-breast-cancer.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.